Tag: N-FIS
Serum Institute to acquire 20% stake in IntegriMedical, India’s first needle-free...
The investment by SII in IntegriMedical is expected to accelerate the development and commercialization of the N-FIS technology, making it more widely accessible to patients in India and worldwide